DUBLIN–(BUSINESS WIRE)–The “United States Precision Medicine Business Investment Opportunities Databook – Q2 2023 Update” report has been added to ResearchAndMarkets.com’s offering.
United States’ precision medicine market size is expected to record a CAGR of 13.2% during 2023-2027 to reach US$43.19 billion by 2027, increasing from US$26.283 billion in 2023. Over the last five years, the sector has recorded a CAGR of 12.9% to reach US$23.274 billion in 2022.
This report provides an in-depth data-centric analysis of the emerging opportunities in the precision medicine industry. It covers a detailed view of market size and forecast across various segments such as by category, technology platform, by technology, by gene sequencing technology, by drugs, by route of administration, by application, and by end-users.
Reasons to Buy
- In-depth understanding of precision medicine market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in United States.
- Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
- Get market share analysis by end-users: Get a detailed analysis across different end-users such as pharmaceuticals and biotechnology companies, diagnostics companies, healthcare IT specialists/big data companies, clinical laboratories within the United States.
Report Scope
Precision medicine market share by category
- Diagnostics
- Therapeutics
- Others
Precision medicine market share by technology platform
- Cloud Based
- On-Premises
Precision medicine market share by technology
- Bioinformatics
- Big Data Analytics
- Drug Discovery
- Companion Diagnostics
- Gene Sequencing
- Others
Precision medicine market share by sequencing technology
- Chain Termination Sequencing
- Nanopore Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Ion Semiconductor Sequencing
- Single Molecule Real Time Sequencing
- Sequencing by Synthesis
Precision medicine market share by drugs
- Mepolizumab
- Osimertinib
- Aripiprazole Lauroxil
- Alectinib
- Others
Precision medicine market share by route of administration
- Injectable
- Oral
- Others
Precision medicine market share by application
- Oncology
- CNS
- Cardiovascular
- Infectious Diseases
- Others
Precision medicine market share by end-user
- Pharmaceuticals and Biotechnology Companies
- Diagnostics Companies
- Healthcare IT Specialists/Big Data Companies
- Clinical Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/w1qpxr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900